Ameera Shah, Promoter and Executive Chairperson of Metropolis Healthcare, discussed the growth potential of the Indian oncology market, and the need for advanced cancer testing.
India's long term growth story is intact despite high valuations and FII outflows in the current markets, says Hofer.
Vineet Agrawal, Co-founder of Jiraaf, a Sebi-registered online bond platform, shared his insights on the Indian bond market, why retail investors should invest in bonds, how to invest, what to expect from bond markets, and more
Swiggy IPO: Sriharsha Majety, Swiggy’s Group CEO & Founder, is confident that the overall grocery business in India will be 25x of the restaurant industry. He believes Instamart will see higher growth rates than food delivery.
Ravi Singh, Senior Vice President (SVP)—Retail Research at Religare Broking, shared his thoughts on investment strategies for HNIs amid market volatility, FII flows between India and China, investment opportunities, sector valuations, and more.
Pawan Bharaddia, Co-founder, Equitree Capital, on what US rate cuts mean for Indian markets, long-term outlook, the firm's investment strategies, and more.
A team of civic body reached northwest Delhi's Bhalswa Dairy colony with bulldozers and heavy deployment of police personnel on Tuesday, prompting locals to stage protest against authorities.
Atul Sobti notes that out of 254 operating PSUs, 74% are profitable; says out Rs 11.11 lakh crore capex target in FY25, over Rs 9 lakh crore is to be achieved by the public sector
"At Hyperface, we are building the most modern, modular and agile technology stack that is revolutionising user experiences of card customers," says Aishwarya Jaishankar.
In conversation with Business Today, Mozaharul Alam, United Nations Environment Programme (UNEP) Coordinator for Climate Action in Asia and the Pacific, talks about the current status of the climate finance efforts, progress on the Fund and India's call for developed countries to provide at least $1 trillion per year in climate finance from 2025
CEO Jonathan Hunt talks about Syngene’s growth amidst challenges in the US biotech sector, biologics’ growth potential, and the company’s future plans.
Copyright©2025 Living Media India Limited. For reprint rights: Syndications Today